2nd May 2014 15:36
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: | (GS) GOLDMAN, SACHS & CO. |
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree | ASTRAZENECA PLC |
(c) Name of the party to the offer with which exempt principal trader is connected: | ASTRAZENECA PLC |
(d) Date position held/dealing undertaken: | 01 May 2014 |
(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? | NO |
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
| ADRs | |||
Interests | Short positions | |||
Number | % | Number | % | |
(1) Relevant securities owned and/or controlled: | 759 | 0.00 | 0 | 0.00 |
(2) Derivatives (other than options): | 0 | 0.00 | 0 | 0.00 |
(3) Options and agreements to purchase/sell: | 0 | 0.00 | 0 | 0.00 |
TOTAL: | 759 | 0.00 | 0 | 0.00 |
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other executive options)
Class of relevant security in relation to which subscription right exists: | |
Details, including nature of the rights concerned and relevant percentages: |
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant security | Purchase/sale
| Number of securities | Price per unit |
ADR | Purchase | 100 | 78.8300 USD |
ADR | Purchase | 100 | 78.8500 USD |
ADR | Purchase | 200 | 78.8800 USD |
ADR | Purchase | 300 | 79.0100 USD |
ADR | Purchase | 100 | 79.0100 USD |
ADR | Purchase | 100 | 79.0600 USD |
ADR | Purchase | 100 | 79.1300 USD |
ADR | Purchase | 100 | 79.1500 USD |
ADR | Purchase | 61 | 79.1500 USD |
ADR | Purchase | 200 | 79.2500 USD |
ADR | Purchase | 100 | 80.5500 USD |
ADR | Purchase | 100 | 80.6900 USD |
ADR | Purchase | 100 | 80.7600 USD |
ADR | Purchase | 300 | 80.8300 USD |
ADR | Purchase | 100 | 80.8500 USD |
ADR | Purchase | 100 | 80.8600 USD |
ADR | Purchase | 200 | 80.8700 USD |
ADR | Purchase | 100 | 80.9400 USD |
ADR | Purchase | 100 | 80.9600 USD |
ADR | Purchase | 18 | 81.0400 USD |
ADR | Purchase | 100 | 81.0500 USD |
ADR | Purchase | 187 | 81.0500 USD |
ADR | Purchase | 213 | 81.0500 USD |
ADR | Purchase | 200 | 81.0600 USD |
ADR | Purchase | 100 | 81.0600 USD |
ADR | Purchase | 200 | 81.0700 USD |
ADR | Purchase | 100 | 81.0700 USD |
ADR | Purchase | 100 | 81.0800 USD |
ADR | Purchase | 200 | 81.0800 USD |
ADR | Purchase | 100 | 81.0800 USD |
ADR | Purchase | 100 | 81.0800 USD |
ADR | Purchase | 100 | 81.0900 USD |
ADR | Purchase | 100 | 81.0900 USD |
ADR | Purchase | 200 | 81.0900 USD |
ADR | Purchase | 100 | 81.0900 USD |
ADR | Purchase | 100 | 81.0900 USD |
ADR | Purchase | 700 | 81.0900 USD |
ADR | Purchase | 100 | 81.1000 USD |
ADR | Purchase | 100 | 81.1000 USD |
ADR | Purchase | 200 | 81.1000 USD |
ADR | Purchase | 100 | 81.1000 USD |
ADR | Purchase | 200 | 81.1000 USD |
ADR | Purchase | 800 | 81.1100 USD |
ADR | Purchase | 100 | 81.1100 USD |
ADR | Purchase | 48 | 81.1100 USD |
ADR | Purchase | 100 | 81.1100 USD |
ADR | Purchase | 155 | 81.1100 USD |
ADR | Purchase | 100 | 81.1200 USD |
ADR | Purchase | 300 | 81.1200 USD |
ADR | Purchase | 200 | 81.1300 USD |
ADR | Purchase | 200 | 81.1400 USD |
ADR | Purchase | 100 | 81.1600 USD |
ADR | Purchase | 100 | 81.1600 USD |
ADR | Purchase | 400 | 81.1600 USD |
ADR | Purchase | 100 | 81.1600 USD |
ADR | Purchase | 100 | 81.1600 USD |
ADR | Purchase | 100 | 81.1600 USD |
ADR | Purchase | 200 | 81.1700 USD |
ADR | Purchase | 200 | 81.1700 USD |
ADR | Purchase | 200 | 81.1700 USD |
ADR | Purchase | 500 | 81.1700 USD |
ADR | Purchase | 300 | 81.1700 USD |
ADR | Purchase | 100 | 81.1700 USD |
ADR | Purchase | 300 | 81.1700 USD |
ADR | Purchase | 100 | 81.1900 USD |
ADR | Purchase | 300 | 81.1900 USD |
ADR | Purchase | 100 | 81.2000 USD |
ADR | Purchase | 200 | 81.2500 USD |
ADR | Purchase | 100 | 81.2700 USD |
ADR | Purchase | 300 | 81.2700 USD |
ADR | Purchase | 300 | 81.2800 USD |
ADR | Purchase | 100 | 81.2800 USD |
ADR | Purchase | 200 | 81.3000 USD |
ADR | Purchase | 100 | 81.3200 USD |
ADR | Purchase | 200 | 81.3200 USD |
ADR | Purchase | 200 | 81.3200 USD |
ADR | Purchase | 100 | 81.3200 USD |
ADR | Purchase | 100 | 81.3200 USD |
ADR | Purchase | 200 | 81.3200 USD |
ADR | Purchase | 100 | 81.3700 USD |
ADR | Purchase | 72 | 81.3700 USD |
ADR | Purchase | 100 | 81.3800 USD |
ADR | Purchase | 28 | 81.3800 USD |
ADR | Purchase | 200 | 81.4200 USD |
ADR | Purchase | 200 | 81.4300 USD |
ADR | Purchase | 100 | 81.4500 USD |
ADR | Purchase | 100 | 81.4600 USD |
ADR | Purchase | 100 | 81.4600 USD |
ADR | Purchase | 200 | 81.4600 USD |
ADR | Purchase | 100 | 81.4600 USD |
ADR | Purchase | 200 | 81.4600 USD |
ADR | Purchase | 200 | 81.4600 USD |
ADR | Purchase | 100 | 81.4900 USD |
ADR | Purchase | 200 | 81.5100 USD |
ADR | Purchase | 100 | 81.5500 USD |
ADR | Purchase | 200 | 81.5500 USD |
ADR | Purchase | 100 | 81.5500 USD |
ADR | Purchase | 100 | 81.5500 USD |
ADR | Purchase | 100 | 81.6100 USD |
ADR | Purchase | 200 | 81.6100 USD |
ADR | Purchase | 40 | 81.6100 USD |
ADR | Purchase | 200 | 81.6300 USD |
ADR | Purchase | 100 | 81.6400 USD |
ADR | Purchase | 100 | 81.6400 USD |
ADR | Purchase | 100 | 81.6400 USD |
ADR | Purchase | 100 | 81.6400 USD |
ADR | Purchase | 200 | 81.6900 USD |
ADR | Purchase | 100 | 81.6900 USD |
ADR | Purchase | 100 | 81.7700 USD |
ADR | Purchase | 100 | 81.7700 USD |
ADR | Purchase | 188 | 81.8300 USD |
ADR | Purchase | 100 | 81.8300 USD |
ADR | Purchase | 300 | 81.8300 USD |
ADR | Purchase | 93 | 81.8700 USD |
ADR | Purchase | 100 | 81.9200 USD |
ADR | Purchase | 200 | 81.9200 USD |
ADR | Purchase | 200 | 81.9600 USD |
ADR | Purchase | 300 | 81.9600 USD |
ADR | Purchase | 100 | 81.9800 USD |
ADR | Purchase | 100 | 82.0000 USD |
ADR | Purchase | 100 | 82.0300 USD |
ADR | Purchase | 800 | 82.0500 USD |
ADR | Purchase | 100 | 82.0600 USD |
ADR | Purchase | 100 | 82.0800 USD |
ADR | Purchase | 100 | 82.0900 USD |
ADR | Purchase | 51 | 82.1100 USD |
ADR | Purchase | 200 | 82.4500 USD |
ADR | Purchase | 100 | 82.4500 USD |
ADR | Purchase | 200 | 82.5000 USD |
ADR | Sale | 100 | 78.8200 USD |
ADR | Sale | 200 | 78.8600 USD |
ADR | Sale | 100 | 78.8700 USD |
ADR | Sale | 400 | 78.9800 USD |
ADR | Sale | 100 | 78.9800 USD |
ADR | Sale | 100 | 79.0000 USD |
ADR | Sale | 25 | 79.1100 USD |
ADR | Sale | 100 | 79.1300 USD |
ADR | Sale | 200 | 79.1300 USD |
ADR | Sale | 400 | 79.1800 USD |
ADR | Sale | 100 | 79.2800 USD |
ADR | Sale | 100 | 80.2300 USD |
ADR | Sale | 100 | 80.6400 USD |
ADR | Sale | 100 | 80.6700 USD |
ADR | Sale | 100 | 80.7000 USD |
ADR | Sale | 300 | 80.7900 USD |
ADR | Sale | 4 | 80.9500 USD |
ADR | Sale | 100 | 80.9600 USD |
ADR | Sale | 200 | 80.9600 USD |
ADR | Sale | 100 | 80.9900 USD |
ADR | Sale | 200 | 80.9900 USD |
ADR | Sale | 400 | 80.9900 USD |
ADR | Sale | 100 | 81.0000 USD |
ADR | Sale | 400 | 81.0200 USD |
ADR | Sale | 200 | 81.0400 USD |
ADR | Sale | 100 | 81.0400 USD |
ADR | Sale | 400 | 81.0500 USD |
ADR | Sale | 100 | 81.0500 USD |
ADR | Sale | 200 | 81.0500 USD |
ADR | Sale | 100 | 81.0500 USD |
ADR | Sale | 100 | 81.0700 USD |
ADR | Sale | 80 | 81.0700 USD |
ADR | Sale | 100 | 81.0800 USD |
ADR | Sale | 400 | 81.0900 USD |
ADR | Sale | 200 | 81.0900 USD |
ADR | Sale | 56 | 81.0900 USD |
ADR | Sale | 100 | 81.1000 USD |
ADR | Sale | 200 | 81.1100 USD |
ADR | Sale | 200 | 81.1100 USD |
ADR | Sale | 200 | 81.1100 USD |
ADR | Sale | 200 | 81.1100 USD |
ADR | Sale | 100 | 81.1100 USD |
ADR | Sale | 100 | 81.1100 USD |
ADR | Sale | 500 | 81.1100 USD |
ADR | Sale | 151 | 81.1100 USD |
ADR | Sale | 100 | 81.1100 USD |
ADR | Sale | 19 | 81.1200 USD |
ADR | Sale | 99 | 81.1200 USD |
ADR | Sale | 37 | 81.1200 USD |
ADR | Sale | 10 | 81.1200 USD |
ADR | Sale | 400 | 81.1300 USD |
ADR | Sale | 200 | 81.1300 USD |
ADR | Sale | 100 | 81.1400 USD |
ADR | Sale | 100 | 81.1500 USD |
ADR | Sale | 200 | 81.1500 USD |
ADR | Sale | 200 | 81.1600 USD |
ADR | Sale | 100 | 81.1700 USD |
ADR | Sale | 100 | 81.1700 USD |
ADR | Sale | 200 | 81.1700 USD |
ADR | Sale | 100 | 81.1700 USD |
ADR | Sale | 100 | 81.1900 USD |
ADR | Sale | 100 | 81.2000 USD |
ADR | Sale | 100 | 81.2000 USD |
ADR | Sale | 100 | 81.2000 USD |
ADR | Sale | 200 | 81.2000 USD |
ADR | Sale | 200 | 81.2000 USD |
ADR | Sale | 200 | 81.2100 USD |
ADR | Sale | 200 | 81.2400 USD |
ADR | Sale | 100 | 81.2500 USD |
ADR | Sale | 100 | 81.2500 USD |
ADR | Sale | 300 | 81.2900 USD |
ADR | Sale | 100 | 81.3000 USD |
ADR | Sale | 200 | 81.3000 USD |
ADR | Sale | 100 | 81.3000 USD |
ADR | Sale | 200 | 81.3100 USD |
ADR | Sale | 200 | 81.3200 USD |
ADR | Sale | 200 | 81.3300 USD |
ADR | Sale | 100 | 81.3300 USD |
ADR | Sale | 200 | 81.3300 USD |
ADR | Sale | 200 | 81.3300 USD |
ADR | Sale | 100 | 81.3400 USD |
ADR | Sale | 200 | 81.3400 USD |
ADR | Sale | 400 | 81.3500 USD |
ADR | Sale | 100 | 81.3700 USD |
ADR | Sale | 100 | 81.3700 USD |
ADR | Sale | 100 | 81.3700 USD |
ADR | Sale | 100 | 81.3900 USD |
ADR | Sale | 200 | 81.4500 USD |
ADR | Sale | 100 | 81.4600 USD |
ADR | Sale | 100 | 81.4600 USD |
ADR | Sale | 100 | 81.5200 USD |
ADR | Sale | 200 | 81.5200 USD |
ADR | Sale | 100 | 81.5200 USD |
ADR | Sale | 200 | 81.5400 USD |
ADR | Sale | 200 | 81.5500 USD |
ADR | Sale | 100 | 81.5800 USD |
ADR | Sale | 100 | 81.6100 USD |
ADR | Sale | 100 | 81.6100 USD |
ADR | Sale | 100 | 81.6100 USD |
ADR | Sale | 100 | 81.6100 USD |
ADR | Sale | 100 | 81.6200 USD |
ADR | Sale | 200 | 81.6200 USD |
ADR | Sale | 300 | 81.6500 USD |
ADR | Sale | 200 | 81.6600 USD |
ADR | Sale | 100 | 81.6700 USD |
ADR | Sale | 100 | 81.6800 USD |
ADR | Sale | 100 | 81.6800 USD |
ADR | Sale | 100 | 81.6900 USD |
ADR | Sale | 100 | 81.7900 USD |
ADR | Sale | 200 | 81.8000 USD |
ADR | Sale | 200 | 81.8300 USD |
ADR | Sale | 100 | 81.8700 USD |
ADR | Sale | 300 | 81.9500 USD |
ADR | Sale | 100 | 81.9600 USD |
ADR | Sale | 100 | 81.9600 USD |
ADR | Sale | 400 | 81.9600 USD |
ADR | Sale | 100 | 82.0500 USD |
ADR | Sale | 100 | 82.0600 USD |
ADR | Sale | 100 | 82.1800 USD |
ADR | Sale | 100 | 82.2000 USD |
ADR | Sale | 100 | 82.2000 USD |
ADR | Sale | 200 | 82.2000 USD |
ADR | Sale | 100 | 82.2000 USD |
ADR | Sale | 100 | 82.4700 USD |
ADR | Sale | 100 | 82.4700 USD |
ADR | Sale | 100 | 82.6800 USD |
Class of relevant security | Purchases/sales | Total number of securities |
ADR | Purchases | 20,854 |
ADR | Sales | 19,581 |
(b) Derivatives transactions (other than options)
Class of relevant security | Product description e.g. CFD | Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit |
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit |
(ii) Exercising
Class of relevant security | Product description e.g. call option | Number of securities | Exercise price per unit |
(d) Other dealings (including subscribing for new securities)
Class of relevant security | Nature of dealing e.g. subscription, conversion | Details | Price per unit (if applicable) |
|
The currency of all prices and other monetary amounts should be stated.
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" |
NONE
|
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" |
NONE
|
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 02 May 2014 |
| Contact name: | Helen-Marie Moloney and Christopher Owers |
| Telephone number: | +44(20) 7774 8019 / +44(20) 7552 1461 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
Related Shares:
Astrazeneca